Global Connected Drug Delivery Devices Market Research Report 2024(Status and Outlook)

Global Connected Drug Delivery Devices Market Research Report 2024(Status and Outlook)

Report Overview

Since the past decade, the healthcare industry has increasingly digitalized with the widespread adoption of connected devices in laboratories & hospitals, electronic health records (EHR), and tablets & smartphones to support healthcare professionals. Opportunely, the widespread accessibility of low-cost connectivity such as near-universal access to technologies such as smartphone and Bluetooth have opened the door to novel opportunities in the healthcare industry.

Connected drug delivery devices are the wireless connected and smart electronic devices that allow patient-administrated therapy. Primarily, these devices are equipped with a sensor that offers various features such as adherence trackers, dosing remainder, and patient education tools. Also, these devices are used for the treatment of various diseases such as multiple sclerosis, diabetes, liver & renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.

The current health crisis highlights the value of migrating some healthcare procedures beyond the confines of the hospital. In some areas, this is already well-developed, notably remote patient monitoring for chronic respiratory conditions and diabetes. Other areas are now playing catch-up; According to BSR, the global market for connected drug delivery devices (injectables and inhalation devices specifically) is projected to reach $ 1293.20 million by 2028 – that is to say a CAGR of over 25% from its $ 266.44 million value in 2021. This projected pace will however depend on a number of key stakeholders and their attitudes towards the development and adoption of these devices. Given the potential of increased digitalisation in improving the efficiency of health services, a careful examination of the healthcare landscape and the factors driving new forms of patient monitoring is constructive.

As the demand for chronic condition therapies grows, an increasing proportion of patients will self-manage and selfadminister in the home, otherwise acute services will be overwhelmed

Connected devices are a critical tool to deliver the data flows which allows clinicians to remotely monitor and manage patient conditions

As staff shortages grow and healthcare demand increases, home administration will accelerate in importance, amplifying the need for digital remote connectivity

Connected drug delivery designers are under pressure to create products that enable connectivity but also minimise wastage, especially of embedded electronics that use rareearth elements

Governments, payers, healthcare providers and pharmaceutical companies are also having to work closely together to establish interoperability data standards, as well as collaboratively mitigating the risk of data protection breaches in a world of connected healthcare devices

From our market research,although interconnected devices have become the development trend of the drug delivery devices market, the business model of connected drug delivery devices market is still in the exploratory stage in the specific commercialization process. every company involved in drug delivery devices either has a connected technology or is developing one. Clinical evidence for improved adherence exists, and evidence for other clinical benefits is mounting. The data infrastructure exists, although systems are not familiar to patients or healthcare professionals yet, and there are legal hurdles to overcome when transferring patient data between legal jurisdictions. Traditional business models have struggled, but innovative business models are progressing.

This report provides a deep insight into the global Connected Drug Delivery Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Connected Drug Delivery Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Connected Drug Delivery Devices market in any manner.

Global Connected Drug Delivery Devices Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Phillips Medisize

Bayer AG

Kindeva

Merck KGaA

Propeller Health

Sulzer Ltd

Biocorp Production SA

OPKO Health

Cohero Health

Elcam Medical

Teva Pharmaceutical Industries Ltd

Sagentia (Science Group)

Proteus Digital Health, Inc

FindAir

Market Segmentation (by Type)

Inhalation Devices

Injectable Devices

Others

Market Segmentation (by Application)

Multiple Sclerosis (MS)

Asthma and COPD

Insulin Injection

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Connected Drug Delivery Devices Market

Overview of the regional outlook of the Connected Drug Delivery Devices Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Connected Drug Delivery Devices Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.